The Europe Leadless Pacemakers Market would witness market growth of 14.9% CAGR during the forecast period (2023-2030).
The market has also witnessed a shift in the demographic profile of patients receiving leadless pacemakers. Initially, these devices were primarily used in older adults who required pacing therapy. However, more recently, leadless pacemakers have been implanted in younger patients, including those with congenital heart diseases. This expansion of the patient population showcases the versatility and applicability of leadless pacemakers in diverse clinical scenarios.
The rising incidence of cardiovascular conditions like atrial fibrillation and bradycardia is primarily responsible for the rising demand for the product. Numerous factors, including unhealthy lifestyle choices, obesity, and diabetes, are accountable for this. Thus, the prevalence of diabetes plays a significant role in the development of heart diseases, which in turn promotes market growth.
Furthermore, recent developments in leadless pacemaker technology have led to the integration of advanced diagnostic and monitoring features. These devices can now not only deliver pacing therapy but also collect and transmit comprehensive cardiac data. The inclusion of diagnostic capabilities, such as heart rate trends, atrial fibrillation detection, and heart failure monitoring, has positioned leadless pacemakers as multifunctional devices capable of providing valuable insights into a patient's cardiac health. This is particularly significant in the growing emphasis on preventive cardiology and the early detection of heart rhythm abnormalities.
The aging demographic in Europe is a prominent factor contributing to the higher prevalence of AF. AF is more common among older individuals, and as life expectancy increases, a more significant segment of the population is at risk of developing this heart rhythm disorder. According to Eurostat, by the year 2050, 129.8 million older people will live in the EU-27, up from 90.5 million at the beginning of 2019. In the EU region, older people are 65 or older. In the EU-27, it is anticipated that the population between the ages of 75 and 84 will rise by 56.1% during this time, while that between the ages of 65 and 74 is expected to rise by 16.6%. On the other hand, according to the most recent estimates, by 2050, there will be 13.5% fewer people in the EU-27 who are under 55.
The increasing prevalence of hypertension in Europe is the result of a complex interplay of factors, including lifestyle choices, an aging population, genetic predisposition, socioeconomic disparities, alcohol and tobacco consumption, and the effects of urbanization. Additionally, high blood pressure is a leading risk factor for AF, which further leads to increased demand for leadless pacemakers. According to Eurostat, in 2019, 22% of people in the EU aged 15 years and over reported having high blood pressure. Therefore, all of these factors will aid in the expansion of the market in the coming years.
The Germany market dominated the Europe Leadless Pacemakers Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $50,839 Thousands by 2030. The UK market is experiencing a CAGR of 13.9% during (2023 - 2030). Additionally, The France market would exhibit a CAGR of 15.8% during (2023 - 2030).
Based on Type, the market is segmented into Micra Transcatheter Pacing System, and Others. Based on End-use, the market is segmented into Hospitals, and Outpatient Facilities. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Leadless Pacemakers Market will Hit $827.7 Million by 2030, at a CAGR of 15.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co., Ltd, Integer Holdings Corporation, MicroPort Scientific Corporation, Osypka AG, Terumo Corporation, and EBR Systems, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Micra Transcatheter Pacing System
- Others
By End-use
- Hospitals
- Outpatient Facilities
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- Lepu Medical Technology Co., Ltd
- Integer Holdings Corporation
- MicroPort Scientific Corporation
- Osypka AG
- Terumo Corporation
- EBR Systems, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Leadless Pacemakers Market, by Type
1.4.2 Europe Leadless Pacemakers Market, by End-use
1.4.3 Europe Leadless Pacemakers Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials & Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Nov – 2023, Sep) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. Europe Leadless Pacemakers Market, By Type
5.1 Europe Micra Transcatheter Pacing System Market, By Country
5.2 Europe Others Market, By Country
Chapter 6. Europe Leadless Pacemakers Market, By End-use
6.1 Europe Hospitals Market, By Country
6.2 Europe Outpatient Facilities Market, By Country
Chapter 7. Europe Leadless Pacemakers Market, By Country
7.1 Germany Leadless Pacemakers Market
7.1.1 Germany Leadless Pacemakers Market, By Type
7.1.2 Germany Leadless Pacemakers Market, By End-use
7.2 UK Leadless Pacemakers Market
7.2.1 UK Leadless Pacemakers Market, By Type
7.2.2 UK Leadless Pacemakers Market, By End-use
7.3 France Leadless Pacemakers Market
7.3.1 France Leadless Pacemakers Market, By Type
7.3.2 France Leadless Pacemakers Market, By End-use
7.4 Russia Leadless Pacemakers Market
7.4.1 Russia Leadless Pacemakers Market, By Type
7.4.2 Russia Leadless Pacemakers Market, By End-use
7.5 Spain Leadless Pacemakers Market
7.5.1 Spain Leadless Pacemakers Market, By Type
7.5.2 Spain Leadless Pacemakers Market, By End-use
7.6 Italy Leadless Pacemakers Market
7.6.1 Italy Leadless Pacemakers Market, By Type
7.6.2 Italy Leadless Pacemakers Market, By End-use
7.7 Rest of Europe Leadless Pacemakers Market
7.7.1 Rest of Europe Leadless Pacemakers Market, By Type
7.7.2 Rest of Europe Leadless Pacemakers Market, By End-use
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.5.4 Geographical Expansions:
8.1.6 SWOT Analysis
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Acquisition and Mergers:
8.3.5.4 Trials & Approval:
8.3.6 SWOT Analysis
8.4 Biotronik SE & Co. KG
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Trials & Approval:
8.4.3 SWOT Analysis
8.5 Lepu Medical Technology Co., Ltd
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 Integer Holdings Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 MicroPort Scientific Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 OSYPKA AG
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Terumo Corporation
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Acquisition and Mergers:
8.9.6 SWOT Analysis
8.10. EBR Systems, Inc.
8.10.1 Company Overview
8.10.2 SWOT Analysis
TABLE 1 Europe Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 2 Europe Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 3 Partnerships, Collaborations and Agreements– Leadless Pacemakers Market
TABLE 4 Product Launches And Product Expansions– Leadless Pacemakers Market
TABLE 5 Acquisition and Mergers– Leadless Pacemakers Market
TABLE 6 Trials & Approvals– Leadless Pacemakers Market
TABLE 7 Europe Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 8 Europe Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 9 Europe Micra Transcatheter Pacing System Market, By Country, 2019 - 2022, USD Thousands
TABLE 10 Europe Micra Transcatheter Pacing System Market, By Country, 2023 - 2030, USD Thousands
TABLE 11 Europe Others Market, By Country, 2019 - 2022, USD Thousands
TABLE 12 Europe Others Market, By Country, 2023 - 2030, USD Thousands
TABLE 13 Europe Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 14 Europe Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 15 Europe Hospitals Market, By Country, 2019 - 2022, USD Thousands
TABLE 16 Europe Hospitals Market, By Country, 2023 - 2030, USD Thousands
TABLE 17 Europe Outpatient Facilities Market, By Country, 2019 - 2022, USD Thousands
TABLE 18 Europe Outpatient Facilities Market, By Country, 2023 - 2030, USD Thousands
TABLE 19 Europe Leadless Pacemakers Market, By Country, 2019 - 2022, USD Thousands
TABLE 20 Europe Leadless Pacemakers Market, By Country, 2023 - 2030, USD Thousands
TABLE 21 Germany Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 22 Germany Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 23 Germany Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 24 Germany Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 25 Germany Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 26 Germany Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 27 UK Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 28 UK Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 29 UK Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 30 UK Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 31 UK Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 32 UK Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 33 France Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 34 France Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 35 France Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 36 France Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 37 France Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 38 France Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 39 Russia Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 40 Russia Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 41 Russia Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 42 Russia Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 43 Russia Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 44 Russia Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 45 Spain Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 46 Spain Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 47 Spain Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 48 Spain Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 49 Spain Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 50 Spain Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 51 Italy Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 52 Italy Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 53 Italy Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 54 Italy Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 55 Italy Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 56 Italy Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 57 Rest of Europe Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 58 Rest of Europe Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 59 Rest of Europe Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 60 Rest of Europe Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 61 Rest of Europe Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 62 Rest of Europe Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 63 Key Information – Medtronic PLC
TABLE 64 Key Information – Abbott Laboratories
TABLE 65 Key Information – Boston Scientific Corporation
TABLE 66 Key Information – Biotronik SE & Co. KG
TABLE 67 Key Information – Lepu Medical Technology Co., Ltd
TABLE 68 Key Information – Integer Holdings Corporation
TABLE 69 key Information – MicroPort Scientific Corporation
TABLE 70 Key Information – OSYPKA AG
TABLE 71 Key Information – Terumo Corporation
TABLE 72 Key Information – EBR Systems, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Leadless Pacemakers Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting the Leadless Pacemakers Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Mergers & Acquisition: 2019, Nov – 2023, Sep) Leading Players
FIG 7 Porter’s Five Forces Analysis - Leadless Pacemakers Market
FIG 8 Europe Leadless Pacemakers Market SHARE, By Type, 2022
FIG 9 Europe Leadless Pacemakers Market SHARE, By Type, 2030
FIG 10 Europe Leadless Pacemakers Market, By Type, 2019 - 2030, USD Thousands
FIG 11 Europe Leadless Pacemakers Market SHARE, By End-use, 2022
FIG 12 Europe Leadless Pacemakers Market SHARE, By End-use, 2030
FIG 13 Europe Leadless Pacemakers Market, By End-use, 2019 - 2030, USD Thousands
FIG 14 Europe Leadless Pacemakers Market SHARE, By Country, 2022
FIG 15 Europe Leadless Pacemakers Market SHARE, By Country, 2030
FIG 16 Europe Leadless Pacemakers Market, By Country, 2019 - 2030, USD Thousands
FIG 17 Recent strategies and developments: Medtronic PLC
FIG 18 SWOT Analysis: Medtronic PLC
FIG 19 Recent strategies and developments: Abbott Laboratories
FIG 20 SWOT Analysis: Abbott Laboratories
FIG 21 Recent strategies and developments: Boston Scientific Corporation
FIG 22 SWOT Analysis: Boston Scientific Corporation
FIG 23 SWOT Analysis: Biotronik SE & Co. KG
FIG 24 SWOT Analysis: Lepu Medical Technology Co., Ltd
FIG 25 SWOT Analysis: Integer Holdings Corporation
FIG 26 SWOT Analysis: MicroPort Scientific Corporation
FIG 27 SWOT Analysis: OSYPKA AG
FIG 28 Recent strategies and developments: Terumo Corporation
FIG 29 SWOT Analysis: Terumo Corporation
FIG 30 SWOT Analysis: EBR Systems, Inc.